A screen for epigenetically silenced microRNA genes in gastrointestinal stromal tumors

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Isosaka, Mai ^a   Niinuma, Takeshi ^b   Nojima, Masanori ^c   Kai, Masahiro ^b   Yamamoto, Eiichiro ^a,b   Maruyama, Reo ^a   Nobuoka, Takayuki ^a   Nishida, Toshirou ^d   Kanda, Tatsuo ^e   Taguchi, Takahiro ^f   Hasegawa, Tadashi ^a   Tokino, Takashi ^a   Hirata, Koichi ^a   Suzuki, Hiromu ^b   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e National Cancer Center Hospital East ^*  (Japan)

^f KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; DECITABINE; DNA; MICRORNA; MICRORNA 152; MICRORNA 155; MICRORNA 203; MICRORNA 335; MICRORNA 34A; MICRORNA 375; MICRORNA 489; MICRORNA 582; MICRORNA 615; MICRORNA 618; MICRORNA 886; MICRORNA 9; UNCLASSIFIED DRUG; 4-PHENYLBUTYRIC ACID; ARYLBUTYRIC ACID DERIVATIVE; AZACITIDINE; MIRN335 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RNA; TUMOR PROTEIN;

AGED; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; PDGFRA GENE; RNA ANALYSIS; UPREGULATION; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; DRUG EFFECTS; GASTROINTESTINAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AZACITIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICRORNAS; NEOPLASM PROTEINS; PHENYLBUTYRATES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, NEOPLASM;

EID: 84941630723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133754     Document Type: Article

References (60)

1. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013; 382 (9896): 973-83. Epub 2013/04/30. doi: 10.1016/S0140-6736(13)60106-3 PMID: 23623056.
2. Wozniak A, Sciot R, Guillou L, Pauwels P, Wasag B, Stul M, et al. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes Chromosomes Cancer. 2007; 46(3): 261-76. Epub 2006/12/16. doi: 10.1002/gcc.20408 PMID: 17171690.
3. Assamaki R, Sarlomo-Rikala M, Lopez-Guerrero JA, Lasota J, Andersson LC, Llombart-Bosch A, et al. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors. Genes Chromosomes Cancer. 2007; 46(6): 564-76. Epub 2007/03/03. doi: 10.1002/gcc.20439 PMID: 17330260.
4. Igarashi S, Suzuki H, Niinuma T, Shimizu H, Nojima M, Iwaki H, et al. A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors. Clin Cancer Res. 2010; 16(21): 5114-23. Epub 2010/10/28. PMID: 20978145.
5. Okamoto Y, Sawaki A, Ito S, Nishida T, Takahashi T, Toyota M, et al. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour. Gut. 2012; 61(3): 392-401. Epub 2011/06/29. doi: 10.1136/gut.2011.241034 PMID: 21708825.
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5 (7): 522-31. Epub 2004/06/24. doi: 10.1038/nrg1379 PMID: 15211354.
7. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6 (4): 259-69. Epub 2006/03/25. nrc1840 PMID: 16557279.
8. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10 (10): 704-14. Epub 2009/09/19. doi: 10.1038/nrg2634 PMID: 19763153.
9. Choi HJ, Lee H, Kim H, Kwon JE, Kang HJ, You KT, et al. MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site. Int J Cancer. 2010; 126(7): 1640-50. Epub 2009/10/02. doi: 10.1002/ijc.24897 PMID: 19795448.
10. Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, et al. Localization-and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol. 2010; 220(1): 71-86. Epub 2009/09/22. doi: 10.1002/path.2610 PMID: 19768731.
11. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012; 72 (5): 1126-36. Epub 2012/01/20. doi: 10.1158/0008-5472.CAN-11-1803 PMID: 22258453.
12. Liu S, Cui J, Liao G, Zhang Y, Ye K, Lu T, et al. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor. Tumour Biol. 2014; 35(9): 9131-8. Epub 2014/07/17. doi: 10.1007/s13277-014-2177-5 PMID: 25027394.
13. Fan R, Zhong J, Zheng S, Wang Z, Xu Y, Li S, et al. MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT. Tumour Biol. 2014; 35(5): 4209-17. Epub 2014/01/01. doi: 10. 1007/s13277-013-1551-z PMID: 24375253.
14. Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA methylation and microRNA dysregulation in cancer. Mol Oncol. 2012; 6(6): 567-78. Epub 2012/08/21. doi: 10.1016/j.molonc.2012.07.007 PMID: 22902148.
15. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, et al. Epigenetic silencing of micro-RNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008; 68(11): 4123-32. Epub 2008/06/04. 68/11/4123 PMID: 18519671. doi: 10.1158/0008-5472.CAN-08-0325
16. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis. 2010; 31(12): 2066-73. Epub 2010/10/07. bgq203 PMID: 20924086. doi: 10.1093/carcin/bgq203
17. Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, Maruyama R, et al. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer. Cancer Res. 2011; 71(17): 5646-58. Epub 2011/07/08. doi: 10.1158/0008-5472.CAN-11-1076 PMID: 21734013.
18. Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, Maruyama R, et al. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Eur Urol. 2013; 63(6): 1091-100. Epub 2012/12/04. doi: 10.1016/j.eururo.2012.11.030 PMID: 23200812.
19. Taguchi T, Sonobe H, Toyonaga S, Yamasaki I, Shuin T, Takano A, et al. Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor. Lab Invest. 2002; 82(5): 663-5. Epub 2002/05/11. PMID: 12004007.
20. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002; 33(5): 459-65. Epub 2002/07/03. S0046817702000151 PMID: 12094370.
21. Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, et al. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA. 2011; 17(6): 1076-89. Epub 2011/04/27. doi: 10.1261/rna.2701111 PMID: 21518807
22. Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003; 125(3): 660-7. PMID: 12949711.
23. Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, Sander C, et al. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One. 2012; 7(3): e33844. Epub 2012/04/06. doi: 10.1371/journal.pone.0033844 PMID: 22479456
24. Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, et al. MiR-34a/c-Dependent PDGFR-alpha/beta Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLoS One. 2013; 8(6): e67581. Epub 2013/06/28. doi: 10.1371/journal.pone.0067581 PMID: 23805317
25. Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, Rimner A, et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 2011; 25(3): 226-31. Epub 2011/02/04. doi: 10.1101/gad.1974211 PMID: 21289068
26. Gong M, Ma J, Guillemette R, Zhou M, Yang Y, Hock JM, et al. miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways. Mol Cancer Res. 2014; 12(1): 101-10. Epub 2013/08/24. doi: 10.1158/1541-7786.MCR-13-0136 PMID: 23966614.
27. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang X, et al. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene. 2012; 31(11): 1398-407. Epub 2011/08/09. doi: 10.1038/onc.2011.340 PMID: 21822301
28. Cao J, Cai J, Huang D, Han Q, Yang Q, Li T, et al. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. Oncol Rep. 2013; 30(2): 701-6. Epub 2013/05/28. doi: 10.3892/or. 2013.2482 PMID: 23708561.
29. Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, et al. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway. Carcinogenesis. 2012; 33(5): 976-85. Epub 2012/03/03. doi: 10.1093/carcin/bgs114 PMID: 22382496
30. Heyn H, Engelmann M, Schreek S, Ahrens P, Lehmann U, Kreipe H, et al. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 2011; 129(12): 2797-806. Epub 2011/05/28. doi: 10.1002/ijc.25962 PMID: 21618216.
31. Dohi O, Yasui K, Gen Y, Takada H, Endo M, Tsuji K, et al. Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. Int J Oncol. 2013; 42(2): 411-8. Epub 2012/12/12. doi: 10. 3892/ijo.2012.1724 PMID: 23229728
32. Wang H, Li M, Zhang R, Wang Y, Zang W, Ma Y, et al. Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299. Tumour Biol. 2013; 34(5): 3101-9. Epub 2013/06/07. doi: 10.1007/s13277-013-0878-9 PMID: 23740614.
33. Gao L, Yang Y, Xu H, Liu R, Li D, Hong H, et al. MiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4. Tumour Biol. 2014; 35(8): 8309-18. Epub 2014/05/27. doi: 10.1007/s13277-014-2092-9 PMID: 24859837.
34. Gao Y, Zeng F, Wu JY, Li HY, Fan JJ, Mai L, et al. MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met. Tumour Biol. 2015; 36(4): 2875-83. Epub 2014/12/11. doi: 10. 1007/s13277-014-2917-6 PMID: 25492484.
35. Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z, et al. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012; 7(7): e40037. Epub 2012/07/18. doi: 10.1371/journal.pone. 0040037 PMID: 22802949
36. Jiang J, Sun X, Wang W, Jin X, Bo X, Li Z, et al. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol. 2012; 29(5): 3472-7. Epub 2012/05/31. doi: 10.1007/s12032-012-0259-z PMID: 22644918.
37. Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W, et al. Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer. 2011; 10: 59. Epub 2011/05/20. doi: 10.1186/1476-4598-10-59 PMID: 21592405
38. Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 2001; 61(9): 3806-9. Epub 2001/04/28. PMID: 11325856.
39. He LR, Zhao HY, Li BK, Liu YH, Liu MZ, Guan XY, et al. Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int J Cancer. 2011; 129(1): 143-50. Epub 2010/09/11. doi: 10.1002/ijc.25669 PMID: 20830705.
40. Tang DJ, Dong SS, Ma NF, Xie D, Chen L, Fu L, et al. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology. 2010; 51(4): 1255-63. Epub 2010/01/30. doi: 10.1002/hep.23451 PMID: 20112425.
41. Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, et al. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Gastroenterology. 2014; 146(7): 1701-13 e9. Epub 2014/02/25. doi: 10.1053/j.gastro.2014.02.029 PMID: 24561231.
42. Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ, Liao YJ, et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelialmesenchymaltransition. Gut. 2012; 61(4): 562-75. Epub 2011/08/05. doi: 10.1136/gutjnl-2011-300207 PMID: 21813470.
43. Peng H, Dara L, Li TW, Zheng Y, Yang H, Tomasi ML, et al. MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology. 2013; 57(6): 2299-313. Epub 2013/01/18. doi: 10.1002/hep.26258 PMID: 23325601
44. Barrowman J, Wiley PA, Hudon-Miller SE, Hrycyna CA, Michaelis S. Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity. Hum Mol Genet. 2012; 21(18): 4084-93. Epub 2012/06/22. doi: 10.1093/hmg/dds233 PMID: 22718200
45. de la Rosa J, Freije JM, Cabanillas R, Osorio FG, Fraga MF, Fernandez-Garcia MS, et al. Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion. Nat Commun. 2013; 4: 2268. Epub 2013/08/07. doi: 10.1038/ncomms3268 PMID: 23917225
46. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007; 447(7148): 1130-4. Epub 2007/06/08. doi: 10.1038/nature05939 PMID: 17554337.
47. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007; 17(15): 1298-307. Epub 2007/07/28. doi: 10.1016/j.cub.2007.06.068 PMID: 17656095.
48. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007; 26 (5): 745-52. Epub 2007/06/02. S1097-2765(07)00310-3 PMID: 17540599
49. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007; 26(5): 731-43. Epub 2007/06/02. S1097-2765(07)00318-8 PMID: 17540598.
50. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescencelike growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A. 2007; 104(39): 15472-7. Epub 2007/09/19. doi: 10.1073/pnas.0707351104 PMID: 17875987
51. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009; 275(1): 44-53. Epub 2008/11/14. doi: 10.1016/j.canlet.2008.09.035 PMID: 19006648.
52. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009; 4(8): e6816. Epub 2009/08/29. doi: 10.1371/journal.pone. 0006816 PMID: 19714243
53. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009; 69(19): 7569-76. Epub 2009/09/24. doi: 10.1158/0008-5472.CAN-09-0529 PMID: 19773441
54. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle. 2008; 7(16): 2591-600. Epub 2008/08/23. PMID: 18719384.
55. Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, et al. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis. 2010; 31(4): 745-50. Epub 2010/02/02. doi: 10.1093/carcin/bgq033 PMID: 20118199.
56. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010; 70(14): 5923-30. Epub 2010/06/24. doi: 10.1158/0008-5472.CAN-10-0655 PMID: 20570894
57. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011; 17(2): 211-5. Epub 2011/01/18. doi: 10.1038/nm.2284 PMID: 21240262
58. Agostini M, Knight RA. miR-34: from bench to bedside. Oncotarget. 2014; 5(4): 872-81. Epub 2014/03/25. 1825 PMID: 24657911
59. Peng Y, Guo JJ, Liu YM, Wu XL. MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression. Biosci Rep. 2014; 34(3). Epub 2014/05/20. PMID: 24837198
60. Nakatani H, Kobayashi M, Jin T, Taguchi T, Sugimoto T, Nakano T, et al. STI571 (Glivec) inhibits the interaction between c-KIT and heat shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1. Cancer Sci. 2005; 96(2): 116-9. Epub 2005/02/23. CAS018 PMID: 15723656.